The Impact of Next-Generation Sequencing on the Diagnosis and Treatment of Epilepsy in Paediatric Patients.
about
Ganaxolone: A New Treatment for Neonatal Seizures.Individualizing Treatment Approaches for Epileptic Patients with Glucose Transporter Type1 (GLUT-1) Deficiency.A Recurrent De Novo PACS2 Heterozygous Missense Variant Causes Neonatal-Onset Developmental Epileptic Encephalopathy, Facial Dysmorphism, and Cerebellar Dysgenesis.Next Generation Sequencing Methods for Diagnosis of Epilepsy Syndromes.De novo mutations of the ATP6V1A gene cause developmental encephalopathy with epilepsy.
P2860
The Impact of Next-Generation Sequencing on the Diagnosis and Treatment of Epilepsy in Paediatric Patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The Impact of Next-Generation ...... ilepsy in Paediatric Patients.
@en
The Impact of Next-Generation ...... ilepsy in Paediatric Patients.
@nl
type
label
The Impact of Next-Generation ...... ilepsy in Paediatric Patients.
@en
The Impact of Next-Generation ...... ilepsy in Paediatric Patients.
@nl
prefLabel
The Impact of Next-Generation ...... ilepsy in Paediatric Patients.
@en
The Impact of Next-Generation ...... ilepsy in Paediatric Patients.
@nl
P2860
P1476
The Impact of Next-Generation ...... pilepsy in Paediatric Patients
@en
P2093
Carla Marini
Renzo Guerrini
P2860
P2888
P304
P356
10.1007/S40291-017-0257-0
P577
2017-08-01T00:00:00Z